I. Melero

Immunology · 2007–2022

A researcher in the Science corpus: 15 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom I. Melero trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Pardoll
  2. P. Matzinger
  3. W. Zou

Who trusts I. Melero overall

  1. S. Farkona

Papers from I. Melero's perspective

Ordered by how strongly the researchers I. Melero trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. (Science)
  2. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies (Journal of Experimental Medicine)
  3. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation (Journal of Experimental Medicine)
  4. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4. (Journal of Clinical Oncology)
  5. Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma (New England Journal of Medicine)
  6. Cancer despite immunosurveillance: immunoselection and immunosubversion (Nature reviews. Immunology)
  7. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (Science)
  8. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. (Annual Review of Immunology)
  9. The B7 family revisited. (Annual Review of Immunology)
  10. Neoantigens in cancer immunotherapy (Science)

Their papers